Ruggeri M, Milan M, La Greca G, Castaman G, Rodeghiero F
Department of Hematology, San Bortolo Hospital, Vicenza, Italy.
Haematologica. 1993 Nov-Dec;78(6 Suppl 2):47-51.
The reported incidence of thromboembolic episodes in people with nephrotic syndrome (NS) ranges from 6% to 44% and it has been ascribed to the presence of a hypercoagulable state, as suggested by abnormalities of several hemostatic parameters in these patients. However, the results of the studies are often contradictory and fragmented and are rarely based on prospective studies. To assess the incidence of venous thrombosis and the pattern of abnormalities of the hemostatic parameters in NS, we planned a prospective study of a group of patients with NS.
Thirty-six consecutive patients with NS were enrolled during a 9-month period. Every 4-6 months, clinical history was collected and physical examination was carried out. Blood samples for laboratory investigation were taken at entry into the study and 24 months later. A critical review of the literature was also carried out (Medline database and Current Contents).
During the follow-up (mean 45.2 months), no thrombotic symptoms were recorded, PTT, PT, TT and mean AT-III levels were within the normal range, whereas fibrinogen, plasminogen, protein C and S, heparin cofactor II levels were significantly higher than normal both at entry into the study and 24 months later. No patient was positive for antiphospholipid antibodies. Slightly decreased levels of AT-III and heparin cofactor II were found in only two cases.
Our study confirms neither the high incidence of thrombotic complications in NS nor the presence of abnormalities of hemostatic parameters commonly associated with venous thromboembolism.
肾病综合征(NS)患者中报道的血栓栓塞事件发生率在6%至44%之间,这归因于高凝状态的存在,这些患者的几个止血参数异常提示了这一点。然而,研究结果往往相互矛盾且零散,很少基于前瞻性研究。为了评估NS患者静脉血栓形成的发生率以及止血参数异常模式,我们计划对一组NS患者进行前瞻性研究。
在9个月期间连续纳入36例NS患者。每4 - 6个月收集临床病史并进行体格检查。在研究开始时和24个月后采集血液样本进行实验室检查。还对文献进行了严格审查(Medline数据库和《现刊目次》)。
在随访期间(平均45.2个月),未记录到血栓形成症状,部分凝血活酶时间(PTT)、凝血酶原时间(PT)、凝血酶时间(TT)和抗凝血酶III(AT - III)平均水平在正常范围内,而纤维蛋白原、纤溶酶原、蛋白C和S、肝素辅因子II水平在研究开始时和24个月后均显著高于正常。没有患者抗磷脂抗体呈阳性。仅在两例患者中发现AT - III和肝素辅因子II水平略有下降。
我们的研究既未证实NS患者血栓形成并发症的高发生率,也未证实通常与静脉血栓栓塞相关的止血参数异常的存在。